Multiple myeloma and immunomodulation: regulating the regulatory cells

Leuk Lymphoma. 2012 Jul;53(7):1253-4. doi: 10.3109/10428194.2012.670233. Epub 2012 Apr 3.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclic AMP / immunology
  • Cyclic AMP / metabolism
  • Dexamethasone / administration & dosage
  • Glucocorticoids / administration & dosage
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunomodulation / drug effects
  • Immunomodulation / immunology*
  • Lenalidomide
  • Male
  • Models, Immunological
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / immunology*
  • Signal Transduction / drug effects
  • Signal Transduction / immunology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism
  • T-Lymphocytes, Regulatory / drug effects
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / metabolism
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives

Substances

  • Glucocorticoids
  • Immunologic Factors
  • Thalidomide
  • Dexamethasone
  • Cyclic AMP
  • Lenalidomide